Letosteine

Letosteine
	File:Letosteine.png
Systematic (IUPAC) name
	2-{2-[(2-ethoxy-2-oxoethyl)thio]ethyl}-1,3-thiazolidine-4-carboxylic acid
Identifiers
CAS Number	53943-88-7
ATC code	R05CB09 (WHO)
PubChem	CID: 68707
DrugBank	DB08939
ChemSpider	61958
UNII	6MVF9U95DW
KEGG	D07380
Synonyms	2-[2-(ethoxycarbonylmethylsulfanyl)ethyl]-1,3-thiazolidine-4-carboxylic acid
Chemical data
Formula	C10H17NO4S2
Molecular mass	279.378 g/mol
	SMILES O=C(O)C1NC(SC1)CCSCC(=O)OCC ;
	InChI InChI=1S/C10H17NO4S2/c1-2-15-9(12)6-16-4-3-8-11-7(5-17-8)10(13)14/h7-8,11H,2-6H2,1H3,(H,13,14) ; Key:IKOCLISPVJZJEA-UHFFFAOYSA-N ;
(what is this?) (verify)

Letosteine is a mucolytic patented (U.S. patent 6987120) by Piero del Soldato of Milan, Italy.^[1] He filed his application in 2000.

References

This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it.